CCL2 and central nervous system cancer: As high levels of CCL2 mRNA expression and the presence of CCL2 were observed in malignant glioma cells in studies in vitro [226,230,231], it became an interesting issue whether any changes of this chemokine also appear in CSF from glioma patients.